Nuvalent, Inc. is a biotechnology company focused on developing targeted therapies for patients with cancer. With a strong foundation in chemistry and structure-based drug discovery, Nuvalent designs innovative small molecules to effectively inhibit kinase targets, overcoming challenges of resistance and selectivity. The company collaborates with physician-scientists to address patient needs and limitations of existing therapies, ensuring their solutions are built for patients and driven by a deep sense of purpose. Nuvalent is committed to using their expertise to deliver precisely targeted cancer treatments.
December 20, 2024
Drive brand strategy and execution at Nuvalent, focusing on oncology medicinal products.
November 19, 2024
As Associate Director of Medical Writing at Nuvalent, lead projects and enhance writing capabilities in cancer treatment.
November 12, 2024
Associate Director driving strategic analytical support for Nuvalent's oncology drug development.
November 10, 2024
Nuvalent creates selective cancer medicines; seeking an Associate Director for drug validation.
November 8, 2024
Nuvalent creates selective medicines, seeking a communications leader for initiatives.
November 6, 2024
Counsel for legal affairs at Nuvalent, a biotech company focused on cancer treatments.
October 31, 2024
Assess drug safety data at Nuvalent, a company focused on cancer treatments.
October 27, 2024
Director managing safety database needs for an oncology-focused company.
October 18, 2024
Nuvalent develops selective cancer medicines through statistical programming leadership.